isospaglumic acid has been researched along with Alzheimer Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Hollinger, KR; Kaplin, AI; Rais, R; Slusher, BS | 1 |
| Cheong, YH; Jo, SA; Kim, H; Kim, MJ; Lee, SK; Park, SI; Youn, HS | 1 |
| Jaarsma, D; Korf, J; Veenma-van der Duin, L | 1 |
| Carter, RE; Coyle, JT; Passani, LA; Vonsattel, JP | 1 |
| Coyle, JT; Passani, LA; Vonsattel, JP | 1 |
5 other study(ies) available for isospaglumic acid and Alzheimer Disease
| Article | Year |
|---|---|
The NAAG'ing Concerns of Modeling Human Alzheimer's Disease in Mice.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Antigens, Surface; Brain; Brain Chemistry; Dipeptides; Disease Models, Animal; Female; Gas Chromatography-Mass Spectrometry; Glutamate Carboxypeptidase II; Humans; Male; Mice; Mice, Inbred C57BL | 2019 |
S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Binding Sites; Cell Line, Tumor; Dipeptides; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Mice; Mice, Transgenic; Molecular Docking Simulation; Mutagenesis, Site-Directed; Organophosphorus Compounds; Proteolysis | 2013 |
N-acetylaspartate and N-acetylaspartylglutamate levels in Alzheimer's disease post-mortem brain tissue.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amygdala; Aspartic Acid; Brain Chemistry; Cerebellar Cortex; Chromatography, High Pressure Liquid; Dipeptides; Female; Hippocampus; Histamine H1 Antagonists; Humans; Male; Middle Aged; Olfactory Bulb; Spectrometry, Fluorescence | 1994 |
N-acetylaspartylglutamate, N-acetylaspartate, and N-acetylated alpha-linked acidic dipeptidase in human brain and their alterations in Huntington and Alzheimer's diseases.
Topics: Alzheimer Disease; Amino Acids; Antigens, Surface; Aspartic Acid; Brain; Case-Control Studies; Cell Count; Dipeptidases; Dipeptides; Glutamate Carboxypeptidase II; Humans; Huntington Disease; Neurons; Neuropeptides; Reference Values | 1997 |
Distribution of N-acetylaspartylglutamate immunoreactivity in human brain and its alteration in neurodegenerative disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antibody Specificity; Antigen-Antibody Reactions; Brain Chemistry; Brain Mapping; Brain Stem; Case-Control Studies; Cerebral Cortex; Dipeptides; Female; Humans; Huntington Disease; Male; Middle Aged; Neuropeptides; Reference Values; Spinal Cord | 1997 |